ArticleJournal of the American Heart Association2023

Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial.

Glenn M Chertow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.